ES8500243A1 - Procedimiento para la obtencion de derivados de la piridazina substituidos en posicion 3, activos sobre el sistema nervioso central - Google Patents

Procedimiento para la obtencion de derivados de la piridazina substituidos en posicion 3, activos sobre el sistema nervioso central

Info

Publication number
ES8500243A1
ES8500243A1 ES529081A ES529081A ES8500243A1 ES 8500243 A1 ES8500243 A1 ES 8500243A1 ES 529081 A ES529081 A ES 529081A ES 529081 A ES529081 A ES 529081A ES 8500243 A1 ES8500243 A1 ES 8500243A1
Authority
ES
Spain
Prior art keywords
group
preparation
nervous system
central nervous
pyridazine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES529081A
Other languages
English (en)
Spanish (es)
Other versions
ES529081A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES529081A0 publication Critical patent/ES529081A0/es
Publication of ES8500243A1 publication Critical patent/ES8500243A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES529081A 1983-01-27 1984-01-23 Procedimiento para la obtencion de derivados de la piridazina substituidos en posicion 3, activos sobre el sistema nervioso central Expired ES8500243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301234A FR2540113A1 (fr) 1983-01-27 1983-01-27 Acides derives de la pyridazine actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
ES529081A0 ES529081A0 (es) 1984-10-01
ES8500243A1 true ES8500243A1 (es) 1984-10-01

Family

ID=9285330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES529081A Expired ES8500243A1 (es) 1983-01-27 1984-01-23 Procedimiento para la obtencion de derivados de la piridazina substituidos en posicion 3, activos sobre el sistema nervioso central

Country Status (27)

Country Link
US (1) US4721711A (enExample)
EP (1) EP0117779B1 (enExample)
JP (1) JPS59141564A (enExample)
KR (1) KR910000638B1 (enExample)
AR (1) AR240045A1 (enExample)
AT (1) ATE48417T1 (enExample)
AU (2) AU2372984A (enExample)
CA (1) CA1238637A (enExample)
DD (1) DD220026A5 (enExample)
DE (1) DE3480653D1 (enExample)
DK (1) DK162985C (enExample)
ES (1) ES8500243A1 (enExample)
FI (1) FI78691C (enExample)
FR (1) FR2540113A1 (enExample)
HU (1) HU193890B (enExample)
IE (1) IE57054B1 (enExample)
IL (1) IL70756A (enExample)
MA (1) MA20018A1 (enExample)
NO (1) NO840313L (enExample)
NZ (1) NZ206945A (enExample)
OA (1) OA07644A (enExample)
PH (1) PH21162A (enExample)
PL (1) PL142340B1 (enExample)
PT (1) PT77993B (enExample)
SG (1) SG93690G (enExample)
YU (1) YU14284A (enExample)
ZA (1) ZA84502B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
EP0190563B1 (de) * 1985-01-14 1989-08-02 Boehringer Ingelheim Kg Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
US5082939A (en) * 1987-01-08 1992-01-21 I.S.F. Societa Per Azioni Pyridazine derivatives
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
US5656631A (en) * 1989-02-07 1997-08-12 Sanofi Pyridazine derivatives
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US20100210590A1 (en) * 1995-09-27 2010-08-19 Northwestern University Compositions and treatments for seizure-related disorders
EP1430033A4 (en) * 2001-08-31 2004-12-15 Univ Northwestern ANTI-INFLAMMATORY AND PROTEIN-INK-INHIBITING COMPOSITION AND THEIR USE
MX2007005247A (es) 2004-11-02 2008-03-13 Univ Northwestern Compuestos de piridazina, composiciones y metodos.
CA2589102C (en) * 2004-11-02 2013-08-13 Northwestern University Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
EP2063894B1 (en) 2006-04-28 2019-08-28 Northwestern University Formulations containing pyridazine compounds for treating neuroinflammatory diseases
CA2650711A1 (en) * 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
EP2015751A2 (en) * 2006-04-28 2009-01-21 Northwestern University Salts of pyridazine compounds
US8283351B2 (en) * 2007-04-02 2012-10-09 Institute For Oneworld Health Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
US20110237528A1 (en) * 2008-09-19 2011-09-29 Institute For Oneworld Health Compositions and methods comprising imidazole and triazole derivatives
US20100267706A1 (en) * 2009-04-20 2010-10-21 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
US4565814A (en) * 1983-01-28 1986-01-21 Sanofi Pyridazine derivatives having a psychotropic action and compositions

Also Published As

Publication number Publication date
US4721711A (en) 1988-01-26
AR240045A1 (es) 1990-01-31
IE840149L (en) 1984-07-27
FR2540113B1 (enExample) 1985-05-17
AU652118B2 (en) 1994-08-18
IE57054B1 (en) 1992-04-08
NZ206945A (en) 1987-07-31
CA1238637A (en) 1988-06-28
ES529081A0 (es) 1984-10-01
PH21162A (en) 1987-08-05
SG93690G (en) 1991-01-18
DD220026A5 (de) 1985-03-20
KR840007586A (ko) 1984-12-08
DK38984A (da) 1984-07-28
AU2372984A (en) 1984-08-02
IL70756A (en) 1987-03-31
ZA84502B (en) 1984-09-26
MA20018A1 (fr) 1984-10-01
ATE48417T1 (de) 1989-12-15
KR910000638B1 (ko) 1991-01-31
DK162985C (da) 1992-06-01
EP0117779B1 (fr) 1989-12-06
AU2142188A (en) 1989-03-16
JPS59141564A (ja) 1984-08-14
OA07644A (fr) 1985-05-23
FI840323A0 (fi) 1984-01-26
IL70756A0 (en) 1984-04-30
FI78691C (fi) 1989-09-11
DK162985B (da) 1992-01-06
NO840313L (no) 1984-07-30
PL245931A1 (en) 1985-07-16
YU14284A (en) 1986-12-31
DE3480653D1 (de) 1990-01-11
HU193890B (en) 1987-12-28
PT77993B (fr) 1986-04-10
FI78691B (fi) 1989-05-31
EP0117779A1 (fr) 1984-09-05
FR2540113A1 (fr) 1984-08-03
FI840323L (fi) 1984-07-28
PL142340B1 (en) 1987-10-31
PT77993A (fr) 1984-02-01
DK38984D0 (da) 1984-01-27

Similar Documents

Publication Publication Date Title
ES8500243A1 (es) Procedimiento para la obtencion de derivados de la piridazina substituidos en posicion 3, activos sobre el sistema nervioso central
GR3024504T3 (en) Cyclic urea derivatives, medicaments contaning them and process for their preparation
HUT53076A (en) Process for producing tetrahydro-1-benz(c,d)indolepropionic acid sulfonamide derivatives and pharmaceutical compositions comprising such compounds
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ZA873978B (en) Benzo(b)thiophene-and benzo(b)furancarboxamide derivatives,their preparation,and pharmaceutical compositions containing them
ES8406477A1 (es) Procedimiento para la preparacion de b-carbolinas
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
DE3581566D1 (de) Oxindol-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ATE28874T1 (de) 3,6-disubstituierte triazolo(3,4a>phthalazinderivate.
SE8703169D0 (sv) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, acid addition salts thereof and process for preparing same
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES8305736A1 (es) Procedimiento para la preparacion de derivados de la piridazina.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
DE3373652D1 (en) Carboximide derivatives, process for their production and medicines containing same
ES8604103A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dialquilaminoalcoxi sustituido y de sus sa-les de adicion acidas y amonicas cuaternarias
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPS57206686A (en) Pyrrolo(2,3-d)carbazole derivative and manufacture
ZA912618B (en) 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ES8303397A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleinetanol o quinoleinpropanol utiles como medicamentos
HU9602226D0 (en) Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them
ES8504122A1 (es) Procedimiento para la obtencion de pirrolidinonas
IL70757A (en) 3-morpholinoethylamino-6-cyclohexyl-or-thienylpyridazine derivatives,their preparation and pharmaceutical compositions containing them
DE3371904D1 (en) Tryptamine derivatives active on the cardiovascular system, and process for their preparation

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201